U.S. Secretary of Labor, Idaho Governor Visit Perpetua Resources to Discuss Stibnite Gold Project Importance to Securing U.S. Jobs and Critical Minerals

Stibnite Gold Project Listed as a White House Transparency Project Perpetua Anticipates 550+ Direct Jobs in Idaho during operations Perpetua Announces Stibnite Launch Scholarship with College of Western Idaho Today, U.S. Secretary of Labor Lori Chavez-DeRemer and Idaho Governor Brad Little met with Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) (“Perpetua Resources” or “Perpetua” or […]

Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug – Hagens Berman

(NASDAQ:REPL), SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune (NASDAQ: REPL) securities between November 22, 2024 and July 21, 2025. The lawsuit comes after

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / WHY: New York, N.Y., August 6, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ:CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the "Class Period"), of the important September

Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug – Hagens Berman

Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug – Hagens Berman REPL Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire August 06, 2025 SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D.

EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. is Investigating Expensify, Inc. on Behalf of Expensify Stockholders and Encourages Investors to Contact the Firm

(NASDAQ:EXFY), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Expensify (EXFY) To Contact Him Directly To Discuss Their Options NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Expensify, Inc. (NASDAQ: EXFY)

EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. is Investigating Expensify, Inc. on Behalf of Expensify Stockholders and Encourages Investors to Contact the Firm

EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. is Investigating Expensify, Inc. on Behalf of Expensify Stockholders and Encourages Investors to Contact the Firm GlobeNewswire August 06, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Expensify (EXFY) To Contact Him Directly To Discuss Their Options NEW YORK, Aug.

Readout – Prime Minister Carney convenes First Ministers’ Meeting

Today, the Prime Minister, Mark Carney, met virtually with provincial and territorial premiers to discuss Canada'sco-ordinated economic response to ongoing U.S. trade measures. The Prime Minister updated the premiers on the status of trade negotiations with the U.S. He noted that, while Canada continues to negotiate with the United States on our trading relationship, the

Investors in Confluent, Inc. (CFLT) Warned of Potential Securities Fraud – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Confluent, Inc. ("Confluent, Inc.") (NASDAQ:CFLT) concerning possible violations of federal securities laws. Confluent issued a press release on July 30, 2025, announcing its financial results for the second quarter of 2025 and

Potential Securities Fraud: Levi & Korsinsky Investigates Exelixis, Inc. (EXEL)

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exelixis, Inc. ("Exelixis, Inc.") (NASDAQ:EXEL) concerning possible violations of federal securities laws. Exelixis issued a press release on July 28, 2025, "reporting financial results for the second quarter of 2025" and "providing

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHVN

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE:BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the "Class Period"), of the important September 12, 2025 lead plaintiff deadline. SO WHAT:

Scroll to Top